Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Platelet Coagulation Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00039416
What this trial is testing

Imatinib Mesylate in Treating Patients With Myelofibrosis

Who this might be right for
Chronic Myelomonocytic LeukemiaEssential ThrombocythemiaPolycythemia Vera+1 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT00005804
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00359463
What this trial is testing

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 33
Testing effectiveness (Phase 2)WithdrawnNCT06176235
What this trial is testing

Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital
Not applicableUnknownNCT00006055
What this trial is testing

Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases

Who this might be right for
Purpura, Schoenlein-HenochGraft Versus Host DiseaseAnemia, Hemolytic, Autoimmune+11 more
Fairview University Medical Center 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT06199089
What this trial is testing

A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 45
Early research (Phase 1)Not Yet RecruitingNCT07599280
What this trial is testing

Universal STAR-T Cell Injection in R/R Autoimmune Diseases.

Who this might be right for
Immune Thrombocytopenia
Jian Zhu 6
Not applicableStudy completedNCT04269603
What this trial is testing

LTA Assessement Using Aggregometer TA-8V (Stago®)

Who this might be right for
Healthy Volunteer
Hospices Civils de Lyon 34
Testing effectiveness (Phase 2)Ended earlyNCT03866577
What this trial is testing

Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
Momenta Pharmaceuticals, Inc. 50
Not applicableStudy completedNCT02466789
What this trial is testing

Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Willebrand Disease (VWD)

Who this might be right for
Von Willebrands Disease
Jonathan Roberts 134
Early research (Phase 1)Study completedNCT03566446
What this trial is testing

CALR Exon 9 Mutant Peptide Vaccine to Patients With CALR-mutant Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasm, UnclassifiableEssential ThrombocythemiaMyelofibrosis
Inge Marie Svane 10
Not applicableStudy completedNCT04466878
What this trial is testing

Prognostic Value of Implementing VCE on Top in Constitutional VWD-patients With GI-bleeding

Who this might be right for
Von Willebrand Diseases
University Hospital, Lille 50
Testing effectiveness (Phase 2)Study completedNCT02273960
What this trial is testing

Study to Evaluate Safety and Efficacy in Adult Subjects With ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Bristol-Myers Squibb 46
Testing effectiveness (Phase 2)Study completedNCT02578706
What this trial is testing

Targeting Platelets in Chronic HIV Infection

Who this might be right for
HIV-1 Infection
Icahn School of Medicine at Mount Sinai 27
Large-scale testing (Phase 3)Study completedNCT00344149
What this trial is testing

Rituximab as Second Line Treatment for ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Ostfold Hospital Trust 112
Not applicableStudy completedNCT07805408
What this trial is testing

A Real World Study of Treatment Patterns and Effectiveness of Standard of Care in Primary Immune Thrombocytopenia Patients

Who this might be right for
Immune Thrombocytopenia
Novartis Pharmaceuticals 3,714
Not applicableWithdrawnNCT00630448
What this trial is testing

Collection of Blood in Normal Subjects and Subjects With Von Willebrand Disease (VWD)

Who this might be right for
Von Willebrand Disease
Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Study completedNCT00448357
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT00424177
What this trial is testing

Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 66
Testing effectiveness (Phase 2)Study completedNCT03830749
What this trial is testing

Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenia
Humanity & Health Medical Group Limited 53
Next Page